Menu
Back to Journals » Cancer Management and Research » Volume 9
Original Research
Comparison of gefitinib as first- and second-line therapy for advanced lung adenocarcinoma patients with positive exon 21 or 19 del epidermal growth factor receptor mutation
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,236 | Dovepress* | 7,630+ | 1,239 | 8,869 | |
| PubMed Central* | 606 | 201 | 807 | ||
| Totals | 8,236 | 1,440 | 9,676 | ||
| *Since 28 June 2017 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 1 | 0 | 1 |
View citations on PubMed Central and Google Scholar